hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse

NCT02960594 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

93

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Lung Cancer
Pancreatic Cancer
Head and Neck Cancer
Ovarian Cancer
ColoRectal Cancer
Gastric Cancer
Esophageal Cancer
HepatoCellular Carcinoma

Interventions

BIOLOGICAL: INO-1400
BIOLOGICAL: INO-9012
BIOLOGICAL: INO-1401

Sponsor

Inovio Pharmaceuticals

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]